Department of Clinical Science, University of Bergen, Bergen, Norway.
Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Cancer Med. 2019 Sep;8(12):5574-5576. doi: 10.1002/cam4.2474. Epub 2019 Aug 8.
Numerous publications have stated that metastases are responsible for 90% of cancer deaths, but data underlying this assertion has been lacking. Our objective was to determine what proportions of cancer deaths are caused by metastases. Population-based data from the Cancer Registry of Norway for the years 2005-2015 was analyzed. We compared all deaths in the Norwegian population where a cancer diagnosis was registered as cause of death. Deaths caused by cancer, with and without metastases, were analyzed, by sex and tumor group. For solid tumors, 66.7% of cancer deaths were registered with metastases as a contributing cause. Proportions varied substantially between tumor groups. Our data support the idea that the majority of deaths from solid tumors are caused by metastases. Thus, a better understanding of the biology of metastases and identification of druggable targets involved in growth at the metastatic site is a promising strategy to reduce cancer mortality.
许多出版物指出,转移是导致 90%癌症死亡的原因,但支持这一说法的数据一直缺乏。我们的目的是确定转移导致了多少癌症死亡。我们分析了 2005-2015 年挪威癌症登记处的基于人群的数据。我们比较了所有在挪威人口中以癌症诊断为死亡原因的死亡。我们按性别和肿瘤组分析了有和没有转移的癌症导致的死亡。对于实体瘤,66.7%的癌症死亡被登记为转移是一个促成因素。比例在肿瘤组之间有很大差异。我们的数据支持这样一种观点,即大多数实体瘤的死亡是由转移引起的。因此,更好地了解转移的生物学特性,并确定在转移部位生长中涉及的可用药靶点,是降低癌症死亡率的一个有前途的策略。